Mcs Laboratories Limited

POWER SEARCH PRICING

SOLUTIONS

mcs laboratories limited Company Information

Company Number

08121022

Next Accounts

Dec 2025

Directors

Angus Malcolm

Alison Malcolm

Shareholders

angus malcolm

alison malcolm

Group Structure

View All

Industry

Other human health activities

Registered Address

. whitecross road, tideswell, derbyshire, SK17 8NY

Website

www.mcslabs.co.uk

mcs laboratories limited Estimated Valuation

£2.5m

Pomanda estimates the enterprise value of MCS LABORATORIES LIMITED at £2.5m based on Net Assets of £1m and 2.49x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Mcs Laboratories Limited is a live company located in derbyshire, SK17 8NY with a Companies House number of 08121022. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2012, it's largest shareholder is angus malcolm with a 50% stake. Mcs Laboratories Limited is a established, small sized company, Pomanda has estimated its turnover at £2.1m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Mcs Laboratories Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating3.5out of 5

3 Strong

4 Regular

5 Weak

Size

annual sales of £2.1m, make it larger than the average company (£730.1k)

Growth

3 year (CAGR) sales growth of -10%, show it is growing at a slower rate (7.2%)

EXPORT

Mcs Laboratories Limited's latest turnover from March 2024 is estimated at £2.1 million and the company has net assets of £1 million. According to their latest financial statements, Mcs Laboratories Limited has 19 employees and maintains cash reserves of £1.1 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Turnover	2,125,636	1,525,536	3,451,127	2,930,533	3,355,288	3,100,877	3,281,376	3,983,240	3,146,769	2,415,082	4,724,692	3,305,132
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,310,713	953,588	2,197,874	1,927,852	2,146,468	2,019,766	2,073,233	2,439,241	1,966,619	1,505,146	2,935,566	1,995,140
Gross Profit	814,923	571,948	1,253,253	1,002,681	1,208,821	1,081,112	1,208,143	1,544,000	1,180,150	909,937	1,789,126	1,309,992
Admin Expenses	1,013,814	716,400	1,226,222	982,586	831,650	956,086	766,933	1,708,994	1,300,696	846,495	1,282,898	941,246
Operating Profit	-198,891	-144,452	27,031	20,095	377,171	125,026	441,210	-164,994	-120,546	63,442	506,228	368,746
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	54,362	47,415	9,526	1,269	1,003	5,751	4,022	1,949	3,355	2,944	1,798	479
Pre-Tax Profit	-144,529	-97,037	36,557	21,364	378,174	130,777	445,232	-163,045	-117,191	66,386	508,026	369,225
Tax	0	0	-6,946	-4,059	-71,853	-24,848	-84,594	0	0	-13,941	-116,846	-88,614
Profit After Tax	-144,529	-97,037	29,611	17,305	306,321	105,929	360,638	-163,045	-117,191	52,445	391,180	280,611
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-144,529	-97,037	29,611	17,305	306,321	105,929	360,638	-163,045	-117,191	52,445	391,180	280,611
Employee Costs	503,418	451,348	405,752	370,462	385,376	378,405	365,096	405,536	1,797,360	1,397,385	2,749,488	1,938,080
Number Of Employees	19	18	17	16	17	17	17	19	85	64	127	90
EBITDA*	-193,003	-135,704	30,224	23,146	380,072	127,885	444,625	-160,326	-114,842	70,249	512,879	372,251

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Tangible Assets	20,032	22,660	26,319	15,294	10,979	11,788	10,245	14,004	17,114	20,431	22,717	26,356
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	20,032	22,660	26,319	15,294	10,979	11,788	10,245	14,004	17,114	20,431	22,717	26,356
Stock & work in progress	7,500	4,900	5,250	3,000	4,500	4,830	4,725	4,985	85,990	87,280	87,930	87,434
Trade Debtors	337,048	247,499	418,522	283,762	394,375	417,438	444,431	389,204	250,131	167,438	310,849	204,063
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	30,743	3,458	0	0	0	0	0	0	0	0	0	0
Cash	1,057,524	1,013,413	1,217,892	1,322,270	1,215,208	791,744	741,812	867,154	692,142	649,914	527,712	191,532
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	1,432,815	1,269,270	1,641,664	1,609,032	1,614,083	1,214,012	1,190,968	1,261,343	1,028,263	904,632	926,491	483,029
total assets	1,452,847	1,291,930	1,667,983	1,624,326	1,625,062	1,225,800	1,201,213	1,275,347	1,045,377	925,063	949,208	509,385
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	1,531	9,947	398,067	387,653	406,630	312,893	395,483	829,593	137,613	121,053	206,891	149,825
Group/Directors Accounts	305,091	9,985	0	0	0	0	0	0	298,595	77,298	67,643	75,778
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	119,261	99,932	0	0	0	0	0	0	0	0	0	0
total current liabilities	425,883	119,864	398,067	387,653	406,630	312,893	395,483	829,593	436,208	198,351	274,534	225,603
loans	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0
provisions	4,626	5,199	6,012	2,380	1,444	2,240	992	1,654	2,024	2,376	2,783	3,071
total long term liabilities	4,626	5,199	6,012	2,380	1,444	2,240	992	1,654	2,024	2,376	2,783	3,071
total liabilities	430,509	125,063	404,079	390,033	408,074	315,133	396,475	831,247	438,232	200,727	277,317	228,674
net assets	1,022,338	1,166,867	1,263,904	1,234,293	1,216,988	910,667	804,738	444,100	607,145	724,336	671,891	280,711
total shareholders funds	1,022,338	1,166,867	1,263,904	1,234,293	1,216,988	910,667	804,738	444,100	607,145	724,336	671,891	280,711

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Operating Activities
Operating Profit	-198,891	-144,452	27,031	20,095	377,171	125,026	441,210	-164,994	-120,546	63,442	506,228	368,746
Depreciation	5,888	8,748	3,193	3,051	2,901	2,859	3,415	4,668	5,704	6,807	6,651	3,505
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	-6,946	-4,059	-71,853	-24,848	-84,594	0	0	-13,941	-116,846	-88,614
Stock	2,600	-350	2,250	-1,500	-330	105	-260	-81,005	-1,290	-650	496	87,434
Debtors	116,834	-167,565	134,760	-110,613	-23,063	-26,993	55,227	139,073	82,693	-143,411	106,786	204,063
Creditors	-8,416	-388,120	10,414	-18,977	93,737	-82,590	-434,110	691,980	16,560	-85,838	57,066	149,825
Accruals and Deferred Income	19,329	99,932	0	0	0	0	0	0	0	0	0	0
Deferred Taxes & Provisions	-573	-813	3,632	936	-796	1,248	-662	-370	-352	-407	-288	3,071
Cash flow from operations	-302,097	-256,790	-99,686	113,159	424,553	48,583	-129,708	473,216	-180,037	114,124	345,529	145,036
Investing Activities
capital expenditure	-3,260	-5,089	-14,218	-7,366	-2,092	-4,402	344	-1,558	-2,387	-4,521	-3,012	-29,861
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-3,260	-5,089	-14,218	-7,366	-2,092	-4,402	344	-1,558	-2,387	-4,521	-3,012	-29,861
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	295,106	9,985	0	0	0	0	0	-298,595	221,297	9,655	-8,135	75,778
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	0	100
interest	54,362	47,415	9,526	1,269	1,003	5,751	4,022	1,949	3,355	2,944	1,798	479
cash flow from financing	349,468	57,400	9,526	1,269	1,003	5,751	4,022	-296,646	224,652	12,599	-6,337	76,357
cash and cash equivalents
cash	44,111	-204,479	-104,378	107,062	423,464	49,932	-125,342	175,012	42,228	122,202	336,180	191,532
overdraft	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	44,111	-204,479	-104,378	107,062	423,464	49,932	-125,342	175,012	42,228	122,202	336,180	191,532

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for mcs laboratories limited. Get real-time insights into mcs laboratories limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for mcs laboratories limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in SK17 area or any other competitors across 12 key performance metrics.

MCS LABORATORIES LIMITED group structure

Mcs Laboratories Limited has no subsidiary companies.

Ultimate parent company

MCS LABORATORIES LIMITED

08121022

MCS LABORATORIES LIMITED Shareholders

angus malcolm	50%
alison malcolm	50%

Mcs Laboratories Limited currently has 2 directors. The longest serving directors include Mr Angus Malcolm (Jun 2012) and Ms Alison Malcolm (Jun 2012).

officer	country	age	start	end	role
Mr Angus Malcolm	England	53 years	Jun 2012	-	Director
Ms Alison Malcolm	England	58 years	Jun 2012	-	Director

P&L

March 2024

turnover

2.1m

+39%

operating profit

-198.9k

gross margin

38.4%

+2.26%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

-0.12%

total assets

1.5m

+0.12%

cash

1.1m

+0.04%

net assets

Total assets minus all liabilities

Similar Companies

clarity healthcare limited

fresenius medical care renal services (idc) limited

4.5

jamie bell physiotherapy limited

3.5

medichem pharmacy ltd

my rightcare (uk) limited

2.5

company number

08121022

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

June 2012

ultimate parent company

None

previous names

N/A

address

. whitecross road, tideswell, derbyshire, SK17 8NY

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to mcs laboratories limited.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MCS LABORATORIES LIMITED. This can take several minutes, an email will notify you when this has completed.

mcs laboratories limited Company Information

mcs laboratories limited Estimated Valuation

mcs laboratories limited Estimated Valuation

mcs laboratories limited Estimated Valuation

Mcs Laboratories Limited Overview

Mcs Laboratories Limited Health Check

MCS LABORATORIES LIMITED financials

mcs laboratories limited Credit Report and Business Information

Mcs Laboratories Limited Competitor Analysis

mcs laboratories limited Ownership

mcs laboratories limited directors

mcs laboratories limited company details

mcs laboratories limited Charges & Mortgages

mcs laboratories limited Capital Raised & Share Issues BETA

mcs laboratories limited Companies House Filings - See Documents